A carregar...
Risk and Benefits of Statins in Glucose Control Management of Type II Diabetes
Worldwide statins are considered to be the first-line pharmacological treatment for dyslipidemia and reducing the risk of coronary heart disease. However, recently various studies have shown its adverse effect on glucose control among diabetic patients and the U.S. Food and Drug Administration have...
Na minha lista:
| Publicado no: | Int J Angiol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Thieme Medical Publishers
2018
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6103774/ https://ncbi.nlm.nih.gov/pubmed/30154630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0036-1572523 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|